Mylan Rolls out Herceptin Biosimilar in India

03-02-2014 Zacks.comComments (0)

BiosimilarsMylan Laboratories

A prevalent phenomenon in the medical sector is the shift in focus of several companies on the highly lucrative biosimilars (generic versions of biologics) market. Biosimilars are expected to be a significant growth driver in the generics industry in ...

Read more on Zacks.com

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top